Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

Clinical trial NCT04639284 · UNKNOWN

Trial details

NCT number: NCT04639284
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Hepatocellular Carcinoma

Start date: 2020-12-23
Primary completion: 2022-07-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.